Model
Edge
Moonlake Immunotherapeutics
0001920780
Filing Type
4
Filing Date
5/4/2022
Updated
5/5/22, 11:49 AM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership